Ardent Health Partners

Ardent Health reported adjusted earnings of $0.12 per share for Q2 2026 (expectation $0.17) on revenue of $1.62 billion, thereby missing the earnings forecast but showing strong operating cash flow of $197 million. Management reaffirmed the full-year outlook for adjusted EBITDA of $485–535 million and highlighted cost cuts, favorable payor contracts and technology initiatives; the IMPACT program now targets savings of more than $70 million. Investors focused on the robust cash generation, the balance sheet with $724 million in cash and the outlook, prompting a sizable after-hours rise in the stock. » Plus sur de.investing.com

Ardent Health reports that physicians and clinical staff have conducted more than one million patient encounters using Ambience Healthcare’s AI documentation platform, which has been deployed across its outpatient network since September 2025. The platform is used in 87% of outpatient visits versus industry benchmarks of 40–45% and saves clinicians on average more than three hours of documentation time per week. Ardent also reports the solution has supported more than 418,000 individual patients and cited an example in which a physician reduced her documentation time per eight hours of face-to-face care by 53%. » Plus sur de.investing.com

Ardent Health Partners shares fell about 14.4% intraday to a 52-week low after Marty Bonick resigned as president and CEO and COO Dave Caspers took over. CFO Alfred Lumsdaine warned of weakening patient volumes in the second quarter; the company is accelerating its operational IMPACT program in response. The confirmed adjusted EBITDA guidance for 2026 of $485–535 million is below the adjusted EBITDA of $545 million in 2025, and class-action lawsuits and analyst downgrades are weighing on sentiment. » Plus sur de.investing.com